Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medeze Group PCLBKK:MEDEZE -1.59%19 FCF Margin % is 11.34% as of Jun. 2026, which is 189% above its 10-year median of 3.93. GuruFocus rates BKK:MEDEZE with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Medeze Group PCL ranks better than 72.04% on this metric.
The historical rank and industry rank for Medeze Group PCL's FCF Margin % or its related term are showing as below:
BKK:MEDEZE'
s FCF Margin % Range Over the Past 10 Years
Min: -2.3 Med: 3.93 Max: 42.23
Current: 10.43
During the past 3 years, the highest FCF Margin % of Medeze Group PCL was 42.23%. The lowest was -2.30%. And the median was 3.93%.
BKK:MEDEZE's FCF Margin % is ranked better than 72.04% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 3.49
vs BKK:MEDEZE: 10.43
The historical data trend for Medeze Group PCL's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:MEDEZE vs HCA, THC, EHC: FCF Margin % Comparison
For the Medical Care Facilities subindustry, Medeze Group PCL's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medeze Group PCL FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medeze Group PCL's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Medeze Group PCL's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medeze Group PCL (BKK:MEDEZE) has a FCF Margin % of 11.34% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medeze Group PCL and its competitors. This is 189% above median its historical median of 3.93. According to the industry distribution chart, Medeze Group PCL ranks #191 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 28%.
Is Medeze Group PCL's FCF Margin % too high?
Medeze Group PCL's current FCF Margin % of 11.34% is 189% above median its 10-year median of 3.93. The Healthcare Providers & Services industry median FCF Margin % is 3.49. Medeze Group PCL's value of 11.34% is 224.9% above this industry median. Based on the distribution chart, Medeze Group PCL ranks #191 out of 683 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Medeze Group PCL has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medeze Group PCL's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medeze Group PCL ranks #191 out of 683 companies for FCF Margin %. This puts Medeze Group PCL in the upper half of its industry. The industry median FCF Margin % is 3.49. Medeze Group PCL's value of 11.34% is 224.9% above this benchmark. While the company's 10-year median is 3.93 vs. the industry median of 3.49, Medeze Group PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.49, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medeze Group PCL's current FCF Margin % of 11.34% is 224.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medeze Group PCL and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medeze Group PCL's current FCF Margin % is 11.34%, which is 189% above median its own 10-year median of 3.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeze Group PCL stock overvalued right now?
Medeze Group PCL (BKK:MEDEZE) has a current FCF Margin % of 11.34%. The current FCF Margin % is 11.34%, which is 189% above median its 10-year median of 3.93 and 224.9% above the Healthcare Providers & Services industry median of 3.49. Medeze Group PCL's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Medeze Group PCL (BKK:MEDEZE), the current FCF Margin % is 11.34% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation and preservation services for medical use. It is organised into four reportable segments: Stem cell sample collection service segment; White blood cell potential testing service segment; Other services segment and Sales of products segment. Geographically, the company operates in Thailand, Vietnam, Cambodia, Philippines, and Other countries, of which maximum revenue is derived from Thailand.
19GF Score
Get the complete analysis for BKK:MEDEZE
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:MEDEZE has been successfully added to your 
